Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 15, Issue 5, 2009, Pages 661-672

  Schippa, Serena ^a   Conte, Maria Pia ^a   Borrelli, Osvaldo ^a   Iebba, Valerio ^a   Aleandri, Marta ^a   Seganti, Lucilla ^a   Longhi, Catia ^a   Chiarini, Fernanda ^a   Osborn, John ^a   Cucchiara, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Dominant genotypes; E. coli; IBD; Mucosa associated; Pediatric patients

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DOMINANT GENE; ENTERITIS; ENZYME ACTIVITY; ESCHERICHIA COLI; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC TRAIT; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; INTESTINE FLORA; MALE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; RECTUM; SCHOOL CHILD; ULCERATIVE COLITIS;

ADOLESCENT; BACTERIAL ADHESION; BACTERIAL TYPING TECHNIQUES; CACO-2 CELLS; CHILD; COLITIS, ULCERATIVE; CROHN DISEASE; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; HUMANS; ILEUM; INTESTINAL MUCOSA; MALE; PROGNOSIS;

EID: 67650333090     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20818     Document Type: Article

References (34)

1. Subramanian S, Campbell BJ, Rhodes JM. Bacteria in the pathogenesis of inflammatory bowel disease. Curr Opin Infect Dis. 2006;19:475-484.
2. Thompson-Chagoyán OC, Maldonado J, Gil A. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response. Clin Nutr. 2005; 24:339-352.
3. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54.
4. Rhodes JM, Black RR, Gallimore R, et al. Histochemical demonstration of desialation and desulphation of normal and inflammatory bowel disease rectal mucus by faecal extracts. Gut. 1985;26:1312-1318.
5. Glasser AL, Boudeau J, Barnich N, et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun. 2001;69:5529-5537.
6. Masseret E, Boudeau J, Colombel JF, et al. Genetically related Escherichia coli strains associated with Crohn's disease. Gut. 2001;48:320-325.
7. Seksik P, Sokol H, Lepage P, et al. The role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24:11-18.
8. Sokol H, Lepage P, Seksik P, et al. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol. 2006; 44:3172-3177.
9. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205-211.
10. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104:13780-13785.
11. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53:1-4.
12. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998;115:1405-1413.
13. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412-421.
14. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127:80-93.
15. Kotlowski R, Bernstein CN, Sepehri S, et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut. 2007;56:610-612.
16. Boudeau J, Barnich N, Darfeuille-Michaud A. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol. 2001;39:1272-1284.
17. Bringer MA, Glasser AL, Tung CH, et al. The Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages. Cell Microbiol. 2006;8:471-484.
18. Campbell BJ, Yu LG, Rhodes JM. Altered glycosylation in inflammatory bowel disease: a possible role in cancer development. Glycoconj J. 2001;18:851-858.
19. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007;117:1566-1574.
20. Bousvaros A, Sylvester F, Kugathasan S, et al. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:885-913.
21. Conte MP, Schippa S, Zamboni I, et al. Gut-associated bacterial microbiota in pediatric patients with inflammatory bowel disease. Gut. 2006; 55:1760-1767.
22. Hyams JS, Ferry G, Mandel FJ. Development and validation of a pediatric Crohn's disease activity index. Pediatr Gastroenterol Nutr. 1991;12:439-447
23. Turner D, Walsh CM, Benchimol EI, et al. Development, validation and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423-432
24. Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology. 1990;98:811-818.
25. Baron JH, Connel AM, Lennard-Jones JE. Variation between observers in describing mucosal appearance in proctocolitis. Br Med J. 1964;1:89-92
26. Conte MP, Venditti M, Chiarini F, et al. Extended spectrum-beta-lactamasi-producing Klebsiella pneumonia outbreaks during a third generation cephalosporin restriction policy. J Chemother. 2005;17: 66-73.
27. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol. 2000; 66:4555-4558.
28. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest. 2007; 87:1042-1054.
29. van Nuenen M, Venema K, van der Woude J, et al. The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci. 2004;49:485-491.
30. Kenny B, DeVinney R, Stein M, et al. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell. 1997;91:511-520.
31. Rumer L, Jores J, Kirsch P, et al. Dissemination of pheU- and pheV-located genomic islands among enteropathogenic (EPEC) and enterohemorrhagic (EHEC) E. coli and their possible role in the horizontal transfer of the locus of enterocyte effacement (LEE). Int J Med Microbiol. 2003;292:463-475.
32. Okeke IN, Borneman JA, Shin S, et al. Comparative sequence analysis of the plasmid-encoded regulator of enteropathogenic Escherichia coli strains. Infect Immun. 2001;69:5553-5564.
33. Yao R, Palchaudhuri S. Nucleotide sequence and transcriptional regulation of a positive regulatory gene of Shigella dysenteriae. Infect Immun. 1992;60:1163-1169.
34. Schultsz C, Moussa M, van Ketel R, et al. Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol. 1997;50:573-579.